Startups
Aquila Biolabs is a German company that develops laboratory devices for the analysis of shake-flask fermentations in biotechnological, chemical, and pharmaceutical research and development. Their sensing products include the Cell Growth Quantifier (CGQ), which is a smart sensor-based technology that offers highly parallelized, non-invasive online monitoring of biomass in shake flasks and other cultivation vessels. Aquila Biolabs was acquired by Scientific Industries on April 30, 2021.
Overview
Employees
11-50
Founded date
2014
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 15, 2022 | Triditive raises €5M towards goal of making 3D printing the go-to technology for overcoming supply disruption | Spanish 3D printer manufacturer Triditive has announced the closure of a €5 million pre-Series A funding round. Led by an investor Triditive describes as ‘an important Spanish industrial group,’ the initiative has seen the company takes its... |
| May 3, 2021 | Seed Fonds II Aachen veräußert Anteile an Biotechnologieunternehmen aquila biolabs GmbH |
Reviews 0
FAQ about Aquila Biolabs
When was Aquila Biolabs founded?
Aquila Biolabs was founded in 2014.
What has the press written about Aquila Biolabs?
Parsers VC has collected 3 articles mentioning Aquila Biolabs, among them “Triditive raises €5M towards goal of making 3D printing the go-to technology for overcoming supply disruption” (Jun 15, 2022) and “Seed Fonds II Aachen veräußert Anteile an Biotechnologieunternehmen aquila biolabs GmbH” (May 3, 2021).
Is Aquila Biolabs still active?
Yes, Aquila Biolabs is active; its latest activity on Parsers VC dates from Aug 8, 2022.